APPLICATION
ANDA087913
TYPE
ANDA
ORIGINAL APPROVAL
1982-06-03
LATEST ACTION
2000-01-28
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
METHYCLOTHIAZIDEDiscontinued
METHYCLOTHIAZIDE 2.5MG · TABLET · ORAL
Approval history
2000-01-28Manufacturing (CMC) · Supplement 11AP
1999-11-23Manufacturing (CMC) · Supplement 10AP
1999-08-20Manufacturing (CMC) · Supplement 9AP
1998-12-09Manufacturing (CMC) · Supplement 8AP
1997-05-30Manufacturing (CMC) · Supplement 7AP
1995-10-24Manufacturing (CMC) · Supplement 6AP
1994-10-21Manufacturing (CMC) · Supplement 5AP
1992-12-04Manufacturing (CMC) · Supplement 4AP
1992-11-05Labeling · Supplement 3AP
1982-11-04Manufacturing (CMC) · Supplement 1AP
1982-11-04Manufacturing (CMC) · Supplement 2AP
1982-06-03OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.